These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

894 related items for PubMed ID: 18295148

  • 1. Attention deficit hyperactivity disorder and substance use disorders.
    Szobot CM, Bukstein O.
    Child Adolesc Psychiatr Clin N Am; 2008 Apr; 17(2):309-23, viii. PubMed ID: 18295148
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The nature of the relationship between attention-deficit/hyperactivity disorder and substance use.
    Wilens TE.
    J Clin Psychiatry; 2007 Apr; 68 Suppl 11():4-8. PubMed ID: 18307375
    [Abstract] [Full Text] [Related]

  • 5. Effect of stimulant medications for attention-deficit/hyperactivity disorder on later substance use and the potential for stimulant misuse, abuse, and diversion.
    Faraone SV, Wilens TE.
    J Clin Psychiatry; 2007 Apr; 68 Suppl 11():15-22. PubMed ID: 18307377
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Is attention-deficit/hyperactivity disorder associated with illicit substance use disorders in male adolescents? A community-based case-control study.
    Szobot CM, Rohde LA, Bukstein O, Molina BS, Martins C, Ruaro P, Pechansky F.
    Addiction; 2007 Jul; 102(7):1122-30. PubMed ID: 17567400
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Safety of stimulant treatment in attention deficit hyperactivity disorder: Part I.
    Merkel RL, Kuchibhatla A.
    Expert Opin Drug Saf; 2009 Nov; 8(6):655-68. PubMed ID: 19785509
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Attention-deficit/hyperactivity disorder and the substance use disorders: the nature of the relationship, subtypes at risk, and treatment issues.
    Wilens TE.
    Psychiatr Clin North Am; 2004 Jun; 27(2):283-301. PubMed ID: 15063998
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Comparing the abuse potential of methylphenidate versus other stimulants: a review of available evidence and relevance to the ADHD patient.
    Kollins SH.
    J Clin Psychiatry; 2003 Jun; 64 Suppl 11():14-8. PubMed ID: 14529325
    [Abstract] [Full Text] [Related]

  • 16. ADHD, substance use disorders, and psychostimulant treatment: current literature and treatment guidelines.
    Kollins SH.
    J Atten Disord; 2008 Sep; 12(2):115-25. PubMed ID: 18192623
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Does stimulant treatment lead to substance use disorders?
    Faraone SV, Wilens T.
    J Clin Psychiatry; 2003 Sep; 64 Suppl 11():9-13. PubMed ID: 14529324
    [Abstract] [Full Text] [Related]

  • 19. Sleep characteristics of children and adolescents with attention deficit-hyperactivity disorder.
    Gruber R.
    Child Adolesc Psychiatr Clin N Am; 2009 Oct; 18(4):863-76. PubMed ID: 19836693
    [Abstract] [Full Text] [Related]

  • 20. Stimulants: use and abuse in the treatment of attention deficit hyperactivity disorder.
    Fone KC, Nutt DJ.
    Curr Opin Pharmacol; 2005 Feb; 5(1):87-93. PubMed ID: 15661631
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 45.